-

EMUCTV: RCC diagnostics in 2026
November 6, 2026UROONCO RCC associate editor Dr. Eduard Roussel (BE) talks to Dr. João Lobo (PT) on Renal Cell Carcinoma...
0 -

EMUCTV: PRIMARY 2 trial
November 5, 2026Dr. Jennifer Le Guévelou (FR) speaks with Prof. Veeru Kasivisvanathan (GB) on the results of the PRIMARY 2...
-

EMUCTV: Histotripsy the new kid on the block final
November 5, 2026Assoc. Prof. Carlotta Palumbo (IT) discusses with Prof. Tze Min Wah (GB) about histotripsy being the new kid...
-

EMUCTV: FinnBladder 9 trial
November 5, 2026Dr. Peter Boström (FI) discusses the FinnBladder 9 trial at EMUC26.
-

Biomarkers drive a new era in GU pathology
November 5, 2026Expert pathologists, radiologists, urologists, and medical oncologists presented and discussed current perspectives and future directions on urological pathology at...
-

The evolving role of AI: To augment or replace clinicians?
November 5, 2026The evolving role of AI: To augment or replace clinicians? “AI will enhance the efficiency of clinicians rather than...
-

EMUCTV: PET FAPI trial
November 5, 2026Dr. Ekaterina Laukhtina (AT) talks about the PET FAPI trial she presented at the EMUC26.
-

EMUCTV: PET Nectin 4 bladder cancer staging
November 5, 2026Prof. Lena Unterrainer (DE) reviews the PET Nectin-4 bladder cancer staging trial at EMUC26.
-

EMUCTV: PET ACP3 trial
November 5, 2026Prof. Philipp Backhaus (DE) elaborates on the PET ACP3 trial he presented at EMUC26.
-

Landmark trials to watch at EMUC26
October 28, 2026Sessions on game-changing trials at the upcoming EMUC26 are one of the congress’s scientific centrepieces. Here are some of...
